Literature DB >> 18241962

Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.

T A Swartz1, M S Green, R Handscher, D Sofer, M Cohen-Dar, T Shohat, S Habib, E Barak, Z Dror, E Somekh, T Peled-Leviathan, R Yulzari, A Libling, E Mendelson, L M Shulman.   

Abstract

Intestinal immunity was studied in a polio-free community immunised with a combined enhanced inactivated/oral polio vaccine (EIPV/OPV) vaccination programme. Poliovirus excretion was evaluated in three groups of infants primed with a partial (2 EIPV+2 OPV) or complete (3 EIPV+3 OPV) dose schedule. Poliovirus replicated in the gut of 59.8-55.8% of infants in the three groups 7 days after administration of an additional OPV dose. Significant decreases in the percent of type-specific-virus excreters appeared after 14 and 21 days for serotypes 1 and 2, and after 21 and 28 days for serotype 3. The percent of excreters was inversely correlated with pre-challenge neutralising antibody (NA) titers (p<0.05). Intrafamilial virus transmission to mothers and siblings was minimal. The principal factor for interruption of disease and virus transmission in the community was a strong and persistent humoral immunity with immunological memory. A satisfactory level of family hygiene contributed towards breaking the chain of transmission of poliovirus to contacts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18241962     DOI: 10.1016/j.vaccine.2007.12.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Successes and shortcomings of polio eradication: a transmission modeling analysis.

Authors:  Bryan T Mayer; Joseph N S Eisenberg; Christopher J Henry; M Gabriela M Gomes; Edward L Ionides; James S Koopman
Journal:  Am J Epidemiol       Date:  2013-04-16       Impact factor: 4.897

2.  Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.

Authors:  Michael Famulare; Christian Selinger; Kevin A McCarthy; Philip A Eckhoff; Guillaume Chabot-Couture
Journal:  PLoS Biol       Date:  2018-04-27       Impact factor: 8.029

3.  Relationship Between Helicobacter pylori IgG Seroprevalence and the Immune Response to Poliovirus Vaccine Among School-Age Children From a Population With Near-Universal Immunity Level.

Authors:  Layaly Badran Abu Zher; Merav Weil; Eias Kassem; Nael Elias; Myron M Levine; Khitam Muhsen
Journal:  Front Med (Lausanne)       Date:  2022-01-20

4.  Vaccines, Social Mobilization, or any Other Game changer: Polio Eradication is an Unfinished Narrative.

Authors:  Sanjay Chaturvedi
Journal:  Indian J Community Med       Date:  2013-04

5.  The Duration of Intestinal Immunity After an Inactivated Poliovirus Vaccine Booster Dose in Children Immunized With Oral Vaccine: A Randomized Controlled Trial.

Authors:  Jacob John; Sidhartha Giri; Arun S Karthikeyan; Dipti Lata; Shalini Jeyapaul; Anand K Rajan; Nirmal Kumar; Pavithra Dhanapal; Jayalakshmi Venkatesan; Mohanraj Mani; Janardhanan Hanusha; Uma Raman; Prabhakar D Moses; Asha Abraham; Sunil Bahl; Ananda S Bandyopadhyay; Mohammad Ahmad; Nicholas C Grassly; Gagandeep Kang
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 7.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.